JP2009531422A - 過分極カルボン酸塩及びスルホン酸塩の製造方法 - Google Patents

過分極カルボン酸塩及びスルホン酸塩の製造方法 Download PDF

Info

Publication number
JP2009531422A
JP2009531422A JP2009502708A JP2009502708A JP2009531422A JP 2009531422 A JP2009531422 A JP 2009531422A JP 2009502708 A JP2009502708 A JP 2009502708A JP 2009502708 A JP2009502708 A JP 2009502708A JP 2009531422 A JP2009531422 A JP 2009531422A
Authority
JP
Japan
Prior art keywords
carboxylate
sulfonate
composition
solution
hyperpolarized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009502708A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009531422A5 (https=
Inventor
レルチェ，マティルダ・エイチ
カールソン，マグナス
Original Assignee
ジーイー・ヘルスケア・アクスイェ・セルスカプ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジーイー・ヘルスケア・アクスイェ・セルスカプ filed Critical ジーイー・ヘルスケア・アクスイェ・セルスカプ
Publication of JP2009531422A publication Critical patent/JP2009531422A/ja
Publication of JP2009531422A5 publication Critical patent/JP2009531422A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/124—Macromolecular compounds dendrimers, dendrons, hyperbranched compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2009502708A 2006-03-29 2007-03-21 過分極カルボン酸塩及びスルホン酸塩の製造方法 Withdrawn JP2009531422A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20061435 2006-03-29
PCT/NO2007/000109 WO2007111515A2 (en) 2006-03-29 2007-03-21 Method to produce hyperpolarised carboxylates and sulphonates

Publications (2)

Publication Number Publication Date
JP2009531422A true JP2009531422A (ja) 2009-09-03
JP2009531422A5 JP2009531422A5 (https=) 2010-04-08

Family

ID=38541547

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009502708A Withdrawn JP2009531422A (ja) 2006-03-29 2007-03-21 過分極カルボン酸塩及びスルホン酸塩の製造方法

Country Status (5)

Country Link
US (1) US20100233096A1 (https=)
EP (1) EP1998813A2 (https=)
JP (1) JP2009531422A (https=)
CN (1) CN101415446A (https=)
WO (1) WO2007111515A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2051739A2 (en) * 2006-08-18 2009-04-29 GE Healthcare AS Imaging medium comprising lactate and hyperpolarised 13c-pyruvate
WO2008086534A1 (en) * 2007-01-11 2008-07-17 Huntington Medical Research Institutes Imaging agents and methods of use thereof
US7470813B2 (en) 2007-03-30 2008-12-30 Ge Healthcare Limited Method for the production of pyruvic acid
CN101970014A (zh) * 2007-07-26 2011-02-09 通用电气医疗集团英国有限公司 包含超极化的13c-乳酸盐的成像介质及其用途
PL2180902T3 (pl) * 2007-08-27 2012-07-31 Ge Healthcare Ltd Ośrodek obrazujący zawierający hiperpolaryzowany ¹³C-octan oraz jego zastosowanie
EP2072061A1 (en) 2007-12-19 2009-06-24 GE Healthcare Limited Composition and method for generating a metabolic profile using 13C-MR detection
JP2011514313A (ja) * 2008-02-04 2011-05-06 ジーイー・ヘルスケア・リミテッド 過分極アミノ酸及びアミノスルホン酸の製造方法
AU2010230330B2 (en) 2009-04-02 2015-06-25 Ge Healthcare Limited Use of a magnetic resonance imaging medium comprising hyperpolarized 13C pyruvate for the detection of inflammation or infection
JP5879333B2 (ja) 2010-05-03 2016-03-08 ジーイー・ヘルスケア・リミテッド Ｌｄｈ活性を決定するための過分極乳酸塩造影剤
US20140328766A1 (en) * 2010-08-24 2014-11-06 Ge Healthcare Limited Composition and method for generating a metabolic profile using 13c-mr detection
US9381257B2 (en) * 2012-07-13 2016-07-05 Bracco Imaging S.P.A. Triarylmethyl radicals
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
ES2814555T3 (es) 2016-11-28 2021-03-29 Bayer Pharma AG Compuestos de quelato de gadolinio con alta relaxividad para usar en la obtención de imágenes por resonancia magnética
KR102934987B1 (ko) 2018-11-23 2026-03-09 바이엘 악티엔게젤샤프트 조영 매체의 제형 및 그의 제조 방법
CN117180458B (zh) * 2023-08-31 2024-08-09 中国科学院精密测量科学与技术创新研究院 草酰乙酸在溶融动态核极化中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3175940B2 (ja) * 1990-02-12 2001-06-11 ニコムド イノベーション アーベー トリアリールメチルラジカルおよび磁気共鳴造影法における不活性炭素フリーラジカルの用途
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
GB9307027D0 (en) * 1993-04-02 1993-05-26 Nycomed Innovation Ab Free radicals
US6278893B1 (en) * 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
US7501236B1 (en) * 1998-12-30 2009-03-10 Ge Healthcare Limited NMR spectroscopic in vitro assay using hyperpolarization
NO20023357D0 (no) * 2002-04-19 2002-07-11 Amersham Health As Blanding
NZ552898A (en) * 2004-07-30 2011-02-25 Ge Healthcare As Method of producing a composition, composition and its use
WO2006011810A2 (en) * 2004-07-30 2006-02-02 Ge Healthcare As Mr imaging method for the discrimination between healthy and tumour tissue
PL1962912T3 (pl) * 2005-12-16 2013-03-29 Ge Healthcare As Sposób wytwarzania hiperpolaryzowanych karboksylanów amin organicznych

Also Published As

Publication number Publication date
US20100233096A1 (en) 2010-09-16
EP1998813A2 (en) 2008-12-10
CN101415446A (zh) 2009-04-22
WO2007111515A2 (en) 2007-10-04
WO2007111515A3 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
JP2009531422A (ja) 過分極カルボン酸塩及びスルホン酸塩の製造方法
JP5475995B2 (ja) 動的核分極（ｄｎｐ）法
CN101506179B (zh) 动态核极化(dnp)的方法及用于所述方法的化合物和组合物
JP2009517688A5 (https=)
JP5535435B2 (ja) ラジカル及び、ｄｎｐ処理における常磁性試薬としてのその使用
CN101378784B (zh) 产生有机胺的超极化羧酸盐的方法
CN101316616B (zh) 应用三苯甲基自由基和顺磁金属离子的动态核极化（dnp）的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100219

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20100219

A072 Dismissal of procedure [no reply to invitation to correct request for examination]

Free format text: JAPANESE INTERMEDIATE CODE: A073

Effective date: 20110712

A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20110802